Association analysis of WNT10B with bone mass and structure among individuals of African ancestry

Journal of Bone and Mineral Research

Volumn 24, Issue 3, 2009, Pages 437-447

  Zmuda, Joseph M ^a,b   Yerges, Laura M ^a   Kammerer, Candace M ^b   Cauley, Jane A ^a   Wang, Xiaojing ^b   Nestlerode, Cara S ^a   Wheeler, Victor W ^c   Patrick, Alan L ^c   Bunker, Clareann H ^a   Moffett, Susan P ^a   Ferrell, Robert E ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Tobago Health Studies Office   (Trinidad and Tobago)

Author keywords

BMD; Genetics; Osteoporosis; Polymorphism; Wnt10b

Indexed keywords

UNCLASSIFIED DRUG; WNT PROTEIN; WNT10B PROTEIN;

ADULT; AFRICA; AFRICAN CARIBBEAN; AGED; ALLELE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MASS; BONE STRUCTURE; CONTROLLED STUDY; DATA BASE; EXON; FAMILY; FAMILY SIZE; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENOTYPE; GEOMETRY; HIP; HUMAN; MALE; PERIOSTEUM; POPULATION; PROTEIN ANALYSIS; RADIUS; REGULATORY MECHANISM; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; WNT10B GENE;

ABSORPTIOMETRY, PHOTON; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; AMINO ACID SEQUENCE; BONE AND BONES; BONE DENSITY; COMPUTATIONAL BIOLOGY; FAMILY CHARACTERISTICS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; ORGAN SIZE; PHENOTYPE; PHYSICAL CHROMOSOME MAPPING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; REPRODUCIBILITY OF RESULTS; RNA; SEQUENCE ANALYSIS, DNA; WNT PROTEINS;

EID: 61849088487     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.081106     Document Type: Article

References (48)

1. Zmuda JM, Sheu YT, Moffett SP 2005 Genetic epidemiology of osteoporosis: Past, present, and future. Curr Osteoporos Rep 3:111-115.
2. Diaz MN, O' Neill TW, Silman AJ 1997 The influence of family history of hip fracture on the risk of vertebral deformity in men and women: The European Vertebral Osteoporosis Study. Bone 20:145-149.
3. Fox KM, Cummings SR, Powell-Threets K, Stone K 1998 Family history and risk of osteoporotic fracture. Osteoporos Int 8:557-562.
4. Johnson ML, Gong G, Kimberling W, Recker SM, Kimmel DB, Recker RR 1997 Linkage of a gene causing high bone mass to human chromosome 11 (11ql2-13). Am J Hum Genet 60:1326-1332.
5. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
6. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
7. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML The Osteoporosis-Pseudoglioma Syndrome Collaborative 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
8. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18:960-974.
9. Koller DL, Rodriguez LA, Christian JC, Slemenda CW, Econs MJ, Hui SL, Morin P, Conneally PM, Joslyn G, Curran ME, Peacock M, Johnston CC, Foroud T 1998 Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11ql2-13. J Bone Miner Res 13:1903-1908.
10. Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE 2004 Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 74:866-875.
11. Koller DL, Ichikawa S, Johnson ML, Lai D, Xuei X, Edenberg HJ, Conneally PM, Hui SL, Johnston CC, Peacock M, Foroud T, Econs MJ 2005 Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 20:75-80.
12. van Meurs JB, Rivadeneira F, Jhamai M, Hugens W, Hofman A, van Leeuwen JP, Pols HA, Uitterlinden AG 2006 Common genetic variation of the low-density lipoprotein receptor- related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res 21:141-150.
13. Kiel DP, Ferrari SL, Cupples LA, Karasik D, Manen D, Imamovic A, Herbert AG, Dupuis J 2007 Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone 40:587-596.
14. van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, Lorenc R, Obermayer-Pietsch B, Ohlsson C, Pettersson U, Reid DM, Rousseau F, Scollen S, Van Hul W, Agueda L, Akesson K, Benevolenskaya LI, Ferrari SL, Hallmans G, Hofman A, Husted LB, Kruk M, Kaptoge S, Karasik D, Karlsson MK, Lorentzon M, Masi L, McGuigan FE, Mellstrom D, Mosekilde L, Nogues X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Weber K, Ioannidis JP, Uitterlinden AG 2008 Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA. 299:1277-90.
15. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: A genome-wide association study. Lancet 371:1505-1512.
16. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA 2005 Regulation of osteo-blastogenesis and bone mass by WntlOb. Proc Natl Acad Sci USA 102:3324-3329.
17. Glynn NW, Meilahn EN, Charron M, Anderson SJ, Kuller LH, Cauley J A 1995 Determinants of bone mineral density in older men. J Bone Miner Res 10:1769-1777.
18. Hill DD, Cauley JA, Sheu Y, Bunker CH, Patrick AL, Baker CE, Beckles GL, Wheeler VW, Zmuda JM 2008 Correlates of bone mineral density in men of African ancestry: The Tobago Bone Health Study. Osteoporos Int 19:227-234.
19. Miljkovic-Gacic I, Ferrell RE, Patrick AL, Kammerer CM, Bunker CH 2005 Estimates of African, European and Native American ancestry in Afro-Caribbean men on the island of Tobago. Hum Hered 60:129-133.
20. Wang X, Kammerer CM, Wheeler VW, Patrick AL, Bunker CH, Zmuda JM 2007 Genetic and environmental determinants of volumetric and areal BMD in multi-generational families of African ancestry: The Tobago Family Health Study. J Bone Miner Res 22:527-536.
21. Schiessl H, Ferretti JL, Tysarczyk-Niemeyer G, Willnecker J 1996 Noninvasive bone strength index as analyzed by peripheral quantitative computed tomography (pQCT). In: Schoneau E (ed.) Paediatric Osteology: New Developments in Diagnostics and Therapy. Elsevier, Amsterdam, The Netherlands, pp. 141-146.
22. Kruglyak L, Nickerson DA, 2001 Variation is the spice of life. Nat Genet 27:234-236.
23. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, Roeder K 2005 Characterization of multilocus linkage disequilibrium. Genet Epidemiol 28:193-206.
24. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, Wang HH, Yao A, Chen YT, Hsu CN 2006 FASTSNP: An always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34:W635-W641.
25. Devlin B, Risch N 1995 A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29:311-322.
26. Stephens M, Smith NJ, Donnelly P 2001 A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
27. Almasy L, Blangero J 1998 Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211.
28. Jiang R, Duan J, Windemuth A, Stephens JC, Judson R, Xu C 2003 Genome-wide evaluation of the public SNP databases. Pharmacogenomics 4:779-789.
29. Ferretti JL, Capozza RF, Zanchetta JR 1996 Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength. Bone 18:97-102.
30. Krishnan V, Bryant HU, Macdougald OA 2006 Regulation of bone mass by Wnt signaling. J Clin Invest 116:1202-1209.
31. Wang X, Kammerer CM, Wheeler VW, Patrick AL, Bunker CH, Zmuda JM 2007 Pleiotropy and heterogeneity in the expression of bone strength-related phenotypes in extended pedigrees. J Bone Miner Res 22:1766-1772.
32. Turner CH, Hsieh YF, Muller R, Bouxsein ML, Rosen CJ, McCrann ME, Donahue LR, Beamer WG 2001 Variation in bone biomechanical properties, microstructure, and density in BXH recombinant inbred mice. J Bone Miner Res 16:206-213.
33. Kang S, Bennett CN, Gerin I, Rapp LA, Hankenson KD, Macdougald OA 2007 Wnt signaling stimulates osteoblasto-genesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J Biol Chem 282:14515-14524.
34. Bennett CN, Hodge CL, MacDougald OA, Schwartz J 2003 Role of Wntl0b and C/EBPalpha in spontaneous adipogenesis of 243 cells. Biochem Biophys Res Commun 302:12-16.
35. Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, Lucas PC, Opp MR, MacDougald OA 2004 WntlOb inhibits development of white and brown adipose tissues. J Biol Chem 279: 35503-35509.
36. Wright WS, Longo KA, Dolinsky VW, Gerin I, Kang S, Bennett CN, Chiang SH, Prestwich TC, Gress C, Burant CF, Susulic VS, MacDougald OA 2007 Wntl0b inhibits obesity in ob/ob and agouti mice. Diabetes 56:295-303.
37. Christodoulides C, Scarda A, Granzotto M, Milan G, Dalla Nora E, Keogh J, De Pergola G, Stirling H, Pannacciulli N, Sethi JK, Federspil G, Vidal-Puig A, Farooqi IS, O'Rahilly S, Vettor R 2006 WNT10B mutations in human obesity. Dia-betologia 49:678-684.
38. Bennett CN, Ouyang H, Ma YL, Zeng Q, Gerin I, Sousa KM, Lane TF, Krishnan V, Hankenson KD, Macdougald OA 2007 Wntl0b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res 22:1924-1932.
39. Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, Haynatzki GR, Babij P, Allen KM, Yaworsky PJ, Bex F, Recker R 2004 Bone biomechanical properties in LRP5 mutant mice. Bone 35:162-169.
40. Sawakami K, Robling AG, Ai M, Pitner ND, Liu D, Warden SJ, Li J, Maye P, Rowe DW, Duncan RL, Warman ML, Turner CH 2006 The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem 281:23698-23711.
41. Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, Kharode Y, Sauter L, Babij P, Brown EL, Hill AA, Akhter MP, Johnson ML, Recker RR, Komm BS, Bex FJ 2006 Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 281:31720-31728.
42. Pedersen JS, Bejerano G, Siepel A, Rosenbloom K, Lindblad-Toh K, Lander ES, Kent J, Miller W, Haussler D 2006 Identification and classification of conserved RNA secondary structures in the human genome. PLOS Comput Biol 2:e33.
43. Hofacker IL 2003 Vienna RNA secondary structure server. Nucleic Acids Res 31:3429-3431.
44. Nielsen KB, Sørensen S, Cartegni L, Corydon TJ, Doktor TK, Schroeder LD, Reinert LS, Elpeleg O, Krainer AR, Gregersen N, Kjems J, Andresen BS 2007 Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: A synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet 80:416-432.
45. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, Cui Y 2007 PolymiRTS Database: Linking polymorphisms in mi-croRNA target sites with complex traits. Nucleic Acids Res 35:D51-D54.
46. Saunders MA, Liang H, Li WH 2007 Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104:3300-3305.
47. Adams BD, Furneaux H, White BA 2007 The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21:1132-1147.
48. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M 2006 A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38:813-818.